ERBB2 and breast carcinoma: A total of 57 deaths from breast cancer were observed in the whole population, and there were 18 deaths (34.0%), 30 deaths (23.6%), and 9 deaths (13.4%) in patients with recurrent tumors of the three HER2 subtypes.